Glucose, insulin, and potassium therapy for heart disease. History of GIK therapy.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000627:therapeutic use*; D006329:Heart Conduction System / Q000503:physiopathology; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D011188:Potassium / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy
D007328:Insulin; D005947:Glucose; D011188:Potassium